IMPlementing IMProved Asthma self-management as RouTine Asthma Asthma UK estimates that 5 million people in the UK have asthma; with good management most should be symptom-free most of the time. Despite this 60,000 people are admitted to hospital with asthma each year; many more attend their GP for emergency care. 1,200 people in the UK die from asthma each year – many of these deaths are preventable. Supported self-management Supported self-management, including engaging in the discussions around a personal asthma action plan, helps people adjust treatment in response to worsening symptoms, improves day-to-day asthma control and reduces the risk of asthma attacks. Our previous project, PRISMS, reviewed all the evidence about asthma self-management. Find out more on the PRISMS website. However, fewer than a quarter of people replying to an Asthma UK web-survey said they had an action plan. We know that people with asthma are well placed to manage their condition themselves - and that this is most successful when there is a combination of support in place to help: patient education professional training and organisational support. We call an approach that addresses all three of these components, ‘supported self-management’. The IMP2ART programme aims to help general practices to embed supported self-management into routine asthma care. The IMP²ART Programme IMP²ART is a programme of work with preliminary projects, developmental work and a UK-wide trial. Developing the IMP²ART intervention The IMP²ART team has developed the components of the IMP²ART implementation strategy to help general practices across the UK to embed supported self-management into routine asthma care. Benefits for people with asthma If successful our strategy and the on-line educational package, experienced facilitators, digital action plans, and review templates, will be immediately ready for roll-out to benefit people with asthma and the NHS. Our aim is to see supported self-management become a routine part of asthma care across the UK. Timeline 01 Oct 2018 – 30 September 2025 This article was published on 2024-09-24